GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Medivation, Inc. (MDVN) President and CEO David Hung sells 10,246 Shares

December 11, 2012 | About:
insider

insider

56 followers
President and CEO of Medivation, Inc. (MDVN) David Hung sells 10,246 shares of MDVN on 12/10/2012 at an average price of $54.42 a share.

Medivation, Inc. has a market cap of $3.84 billion; its shares were traded at around $55.65 with and P/S ratio of 33.9. Medivation, Inc. had an annual average earning growth of 85.2% over the past 5 years.

This is the annual revenues and earnings per share of MDVN over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of MDVN.


CEO Recent Trades:



  • President and CEO David Hung sold 10,246 shares of MDVN stock on 12/10/2012 at the average price of 54.42. David Hung owns at least 2,203,715 shares after this. The price of the stock has increased by 2.26% since.
  • President and CEO David Hung sold 50,000 shares of MDVN stock on 10/04/2012 at the average price of 57.92. David Hung owns at least 2,182,961 shares after this. The price of the stock has decreased by 3.92% since.
  • President and CEO David Hung sold 25,000 shares of MDVN stock on 09/04/2012 at the average price of 111.16. David Hung owns at least 1,125,334 shares after this. The price of the stock has decreased by 49.94% since.
  • President and CEO David Hung sold 25,000 shares of MDVN stock on 07/03/2012 at the average price of 95.05. David Hung owns at least 1,150,334 shares after this. The price of the stock has decreased by 41.45% since.

CFO Recent Trades:



  • Chief Business Officer and CFO Clarence Patrick Machado sold 20,000 shares of MDVN stock on 10/03/2012 at the average price of 55.54. Clarence Patrick Machado owns at least 36,549 shares after this. The price of the stock has increased by 0.2% since.
  • Chief Business Officer and CFO Clarence Patrick Machado sold 20,000 shares of MDVN stock on 09/07/2012 at the average price of 105.74. Clarence Patrick Machado owns at least 21,511 shares after this. The price of the stock has decreased by 47.37% since.
  • Chief Business Officer and CFO Clarence Patrick Machado sold 10,000 shares of MDVN stock on 07/02/2012 at the average price of 94.11. Clarence Patrick Machado owns at least 21,511 shares after this. The price of the stock has decreased by 40.87% since.

This is the insider trade history vs. stock price of MDVN. For the complete insider trading history of MDVN, click here.




Directors and Officers Recent Trades:



  • Director Gregory Bailey sold 16,800 shares of MDVN stock on 10/24/2012 at the average price of 53.6. Gregory Bailey owns at least 447,330 shares after this. The price of the stock has increased by 3.82% since.
  • Director Gregory Bailey sold 3,200 shares of MDVN stock on 10/16/2012 at the average price of 53.5. Gregory Bailey owns at least 464,130 shares after this. The price of the stock has increased by 4.02% since.
  • Director Gregory Bailey sold 40,000 shares of MDVN stock on 10/05/2012 at the average price of 58.1. Gregory Bailey owns at least 467,330 shares after this. The price of the stock has decreased by 4.22% since.
  • Director Gregory Bailey sold 30,000 shares of MDVN stock on 10/02/2012 at the average price of 56.39. Gregory Bailey owns at least 507,330 shares after this. The price of the stock has decreased by 1.31% since.
  • Director Daniel Adams sold 88,038 shares of MDVN stock on 09/27/2012 at the average price of 55.69. The price of the stock has decreased by 0.07% since.


For the complete insider trading history of MDVN, click here.

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 3.0/5 (2 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide